Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Emily Sterbis

Concepts (69)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Embolization, Therapeutic
2
2026
242
0.830
Why?
Vena Cava Filters
1
2023
64
0.720
Why?
Osteoarthritis, Knee
1
2022
280
0.590
Why?
Knee Joint
1
2022
428
0.570
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1189
0.380
Why?
Lung Neoplasms
1
2022
2664
0.280
Why?
Neoplasms
1
2023
2906
0.250
Why?
Arteriovenous Malformations
1
2026
32
0.240
Why?
Pulmonary Veins
1
2026
107
0.220
Why?
Watchful Waiting
1
2023
90
0.180
Why?
Device Removal
1
2023
142
0.170
Why?
Fluorodeoxyglucose F18
1
2022
161
0.170
Why?
Radiopharmaceuticals
1
2022
205
0.170
Why?
Positron Emission Tomography Computed Tomography
1
2022
117
0.170
Why?
Arteries
1
2022
261
0.160
Why?
Arthritis, Infectious
2
2018
76
0.160
Why?
Positron-Emission Tomography
1
2022
343
0.160
Why?
Pulmonary Artery
1
2026
1127
0.160
Why?
Pain Management
1
2022
410
0.140
Why?
Retrospective Studies
5
2026
17291
0.140
Why?
Blood Loss, Surgical
1
2018
113
0.130
Why?
Prosthesis-Related Infections
1
2018
98
0.130
Why?
Pain
1
2022
789
0.130
Why?
Warfarin
1
2018
179
0.120
Why?
Medicare
1
2022
903
0.120
Why?
Arthroplasty, Replacement, Knee
2
2018
374
0.120
Why?
Arthroplasty, Replacement, Hip
1
2018
182
0.110
Why?
Osteoarthritis
1
2018
200
0.110
Why?
Preoperative Care
1
2018
380
0.110
Why?
Reoperation
1
2018
633
0.110
Why?
Prediabetic State
1
2018
249
0.110
Why?
Aspirin
1
2018
406
0.100
Why?
Platelet Aggregation Inhibitors
1
2018
499
0.100
Why?
Venous Thromboembolism
1
2018
328
0.100
Why?
Anticoagulants
1
2018
748
0.090
Why?
Cohort Studies
1
2023
6013
0.090
Why?
Aged
5
2026
26153
0.080
Why?
Middle Aged
5
2026
36215
0.070
Why?
Mass Screening
1
2018
1360
0.070
Why?
Humans
7
2026
145475
0.070
Why?
Retreatment
1
2026
79
0.060
Why?
Postoperative Complications
1
2018
2970
0.050
Why?
United States
1
2022
16098
0.050
Why?
Male
5
2026
72843
0.050
Why?
Female
5
2026
78845
0.050
Why?
Aged, 80 and over
3
2018
8333
0.040
Why?
Incidence
2
2018
2923
0.040
Why?
Young Adult
3
2026
14219
0.040
Why?
International Normalized Ratio
1
2018
55
0.030
Why?
Philadelphia
1
2018
55
0.030
Why?
Tranexamic Acid
1
2018
59
0.030
Why?
Adult
4
2026
40777
0.030
Why?
Elective Surgical Procedures
1
2018
202
0.030
Why?
Diabetes Complications
1
2018
224
0.030
Why?
Drug Administration Schedule
1
2018
782
0.030
Why?
Venous Thrombosis
1
2018
196
0.030
Why?
Pulmonary Embolism
1
2018
241
0.030
Why?
Blood Transfusion
1
2018
409
0.030
Why?
Risk Factors
2
2018
10885
0.020
Why?
Dose-Response Relationship, Drug
1
2018
2028
0.020
Why?
Logistic Models
1
2018
2134
0.020
Why?
Treatment Outcome
1
2026
11772
0.020
Why?
Prevalence
1
2018
2865
0.020
Why?
Diabetes Mellitus
1
2018
1097
0.020
Why?
Blood Glucose
1
2018
2341
0.020
Why?
Adolescent
1
2026
22530
0.020
Why?
Child
1
2026
22707
0.010
Why?
Prospective Studies
1
2018
8057
0.010
Why?
Diabetes Mellitus, Type 2
1
2018
2588
0.010
Why?
Sterbis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)